HIV-1 vaccine (University of Oxford/ReiThera)

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameHIV-1 vaccine (University of Oxford/ReiThera)
Drug Alias NameAd35-GRINChAdV63.HIVconsvAdCh3NSmutI/ChAdV63.HIVconsv
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis CHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Oxford
Active IndicationsHIV Infections
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A